Helicos Genetics Patent Ruled Invalid In Illumina Row

Law360, New York (August 29, 2012, 3:15 PM EDT) -- A patent infringement crusade embarked upon by Helicos BioSciences Corp. ended on Tuesday as a Delaware federal judge found Helicos' remaining genetics analysis patent invalid, letting Illumina Inc. off the hook for allegedly incorporating it into its scanning technology.

U.S. District Judge Sue L. Robinson allowed Illumina, the last remaining defendant in the case, to exit after determining that the genetics analysis invention asserted by Helicos was not covered by the language of its patent description, granting Illumina's motion for summary judgment on invalidity.

“In sum,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.